trial, no events associated generic for sarafem discontinuation generic for sarafem an incidence of 2% for SARAFEM 20 generic for sarafem In these clinical trials, more than one event may have been recorded as the cause generic for sarafem discontinuation.Associated with discontinuation in US depression, OCD, and bulimia placebo-controlled clinical trials (excluding data.

that may affect the serotonergic neurotransmitter systems, generic for sarafem as triptans, linezolid (an antibiotic which is a reversible non-selective MAOI), lithium, generic for sarafem or generic for sarafem generic for sarafem Wort (see Serotonin Syndrome under WARNINGS). The concomitant use of SARAFEM with other generic for sarafem SNRIs or tryptophan is not recommended (see Tryptophan).Triptans — There have been rare postmarketing reports of serotonin syndrome with use of an SSRI and generic for sarafem triptan. If concomitant treatment of SARAFEM with a triptan is clinically warranted, careful observation of the patient generic for sarafem advised, particularly during generic for sarafem initiation and dose increases (see Serotonin generic for sarafem under WARNINGS).Potential effects of coadministration of generic for sarafem tightly bound to plasma proteins generic for sarafem Because fluoxetine is tightly bound to plasma protein, the administration of generic for sarafem to a patient generic for sarafem another generic for sarafem that generic for sarafem tightly bound to protein (e.g., warfarin, digitoxin) may cause generic for sarafem shift in plasma concentrations potentially resulting generic for sarafem an generic for sarafem effect. Conversely.

PMDD of orgasmic dysfunction, including anorgasmia.There are no adequate generic for sarafem well-controlled studies.